Moderna (MRNA) News Today $39.39 -0.17 (-0.43%) (As of 12/20/2024 05:45 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Is Moderna Stock a Buy?December 20 at 6:45 AM | fool.com3 Stocks That Could Turn $1,000 into $5,000 by 2030December 20 at 4:50 AM | fool.comPersonalis receives $50M investment from Merck, extends pact with ModernaDecember 19 at 9:43 PM | markets.businessinsider.comModerna, Inc. (MRNA) Faces Criticism from Cramer Amid High R&D Spending and Revenue StrugglesDecember 19 at 4:46 PM | insidermonkey.comArgus Research Downgrades Moderna (MRNA)December 19 at 4:49 AM | msn.comStifel Financial Corp Cuts Stock Position in Moderna, Inc. (NASDAQ:MRNA)Stifel Financial Corp reduced its position in Moderna, Inc. (NASDAQ:MRNA - Free Report) by 32.4% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 41,917 shares of the company's stock afterDecember 19 at 3:32 AM | marketbeat.comModerna downgraded to Hold from Buy at ArgusDecember 18 at 6:48 PM | markets.businessinsider.comArgus downgrades Moderna to hold on weak near-term outlookDecember 18 at 6:48 PM | finance.yahoo.comAustralia’s first mRNA Covid vaccine candidate could solve ‘immune imprinting’ problem — here’s what that could meanDecember 18 at 6:48 PM | nypost.comThis Feels Like the Post-Pandemic Rally. 3 Stocks to Buy If It IsDecember 18 at 11:13 AM | 247wallst.comArgus Downgrades Moderna (NASDAQ:MRNA) to HoldArgus downgraded Moderna from a "buy" rating to a "hold" rating in a research report on Wednesday.December 18 at 8:15 AM | marketbeat.com3 No-Brainer Biotech Stocks to Buy With $200 Right NowDecember 18 at 5:44 AM | fool.comModerna: Cutting Costs Might Not Be EnoughDecember 18 at 2:43 AM | seekingalpha.comModerna pauses its RSV vaccine trial for children after 5 infants are hospitalized in latest challenge of preventing diseaseDecember 17, 2024 | msn.comMicroStrategy, Palantir, Axon to join the Nasdaq 100 next weekDecember 16, 2024 | finance.yahoo.comWhat's Going On Moderna Stock On Monday?December 16, 2024 | benzinga.comIs Moderna Stock Underperforming the Dow?December 16, 2024 | msn.comBrokerages Set Moderna, Inc. (NASDAQ:MRNA) PT at $79.50December 16, 2024 | americanbankingnews.comCambridge drugmaker wins city approval to put its sign above the treelineDecember 15, 2024 | bizjournals.comQuantinno Capital Management LP Decreases Stake in Moderna, Inc. (NASDAQ:MRNA)Quantinno Capital Management LP cut its stake in Moderna, Inc. (NASDAQ:MRNA - Free Report) by 85.7% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 9,406 shares of the company's stock after selling 56,562December 15, 2024 | marketbeat.comToronto Dominion Bank Increases Stock Position in Moderna, Inc. (NASDAQ:MRNA)Toronto Dominion Bank increased its position in shares of Moderna, Inc. (NASDAQ:MRNA - Free Report) by 23.7% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 131,477 shares of the company's stock after buying an additionalDecember 14, 2024 | marketbeat.comModerna Target of Unusually High Options Trading (NASDAQ:MRNA)December 14, 2024 | americanbankingnews.comThe specter of RFK Jr. has investors fretting about a onetime vaccine wunderkindDecember 13, 2024 | msn.comIs Moderna Stock A Sell In December 2024 With Deep Losses Projected For The Fourth Quarter?December 13, 2024 | yahoo.comPalantir, MicroStrategy Could Be Added to Nasdaq 100 Friday. Moderna, Super Micro Could Be Dropped.December 13, 2024 | barrons.comModerna, Inc. (NASDAQ:MRNA) Shares Acquired by Geode Capital Management LLCGeode Capital Management LLC lifted its stake in shares of Moderna, Inc. (NASDAQ:MRNA - Free Report) by 2.6% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 7,069,580 shares of the company's stock after buying an additional 178December 13, 2024 | marketbeat.comModerna, Inc. (NASDAQ:MRNA) Given Consensus Rating of "Hold" by AnalystsShares of Moderna, Inc. (NASDAQ:MRNA - Get Free Report) have received a consensus rating of "Hold" from the twenty-one analysts that are presently covering the firm, Marketbeat.com reports. Four research analysts have rated the stock with a sell rating, eleven have given a hold rating, five have giDecember 13, 2024 | marketbeat.comSK bioscience Receives Approval for Global Clinical Trials of mRNA Japanese Encephalitis Vaccine CandidateDecember 12, 2024 | prnewswire.comThese Are the 5 Worst-Performing Stocks in the S&P 500 With 2024 Almost OverDecember 12, 2024 | fool.comBofA downgrades Moderna, says it's 'tough time' to be vaccine makerDecember 12, 2024 | finance.yahoo.comModerna, Inc. (NASDAQ:MRNA) Insider Shannon Thyme Klinger Sells 529 SharesDecember 11, 2024 | insidertrades.comNational Bank of Canada FI Acquires 90,739 Shares of Moderna, Inc. (NASDAQ:MRNA)National Bank of Canada FI grew its stake in Moderna, Inc. (NASDAQ:MRNA - Free Report) by 62.8% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 235,266 shares of the company's stock after purchasing an additiDecember 11, 2024 | marketbeat.commRNA Vaccines and Therapeutics Industry Forecast to Generate Over $72 Billion in Revenues by 2032 - Breakdown by Vaccine Type, Treatment Type, Vaccine Manufacturing, Application, End-user, and RegionDecember 11, 2024 | globenewswire.comModerna Stock Is Struggling. BofA Doesn’t See Things Getting Better.December 10, 2024 | msn.comModerna's (MRNA) Underperform Rating Reiterated at Bank of AmericaBank of America reaffirmed an "underperform" rating and issued a $41.00 target price on shares of Moderna in a research report on Tuesday.December 10, 2024 | marketbeat.comThis Popular ETF (and These 6 Stocks) Are Set to Lose in Trump 2.0December 9, 2024 | marketbeat.comCarisma Therapeutics Announces Strategic Restructuring to Re-prioritize PipelineDecember 9, 2024 | prnewswire.comY Intercept Hong Kong Ltd Has $6.76 Million Stock Position in Moderna, Inc. (NASDAQ:MRNA)Y Intercept Hong Kong Ltd boosted its position in Moderna, Inc. (NASDAQ:MRNA - Free Report) by 30.9% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 101,159 shares of the company's stock after acquiring an additionaDecember 9, 2024 | marketbeat.commRNA Therapeutics Market Size to Hit USD 48.65 Billion by 2032 due to Advances in Cancer Treatment and Expanding mRNA Vaccine Applications | Research by SNS InsiderDecember 8, 2024 | globenewswire.comXTX Topco Ltd Buys 25,400 Shares of Moderna, Inc. (NASDAQ:MRNA)XTX Topco Ltd raised its stake in Moderna, Inc. (NASDAQ:MRNA - Free Report) by 889.4% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 28,256 shares of the company's stock after buying an additional 25,400 shares duringDecember 8, 2024 | marketbeat.comModerna, Inc. (NASDAQ:MRNA) Shares Purchased by Wellington Management Group LLPWellington Management Group LLP raised its stake in Moderna, Inc. (NASDAQ:MRNA - Free Report) by 21.0% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 5,224,685 shares of the company's stock after acquiring aDecember 8, 2024 | marketbeat.comWeiss Asset Management LP Makes New $2.47 Million Investment in Moderna, Inc. (NASDAQ:MRNA)Weiss Asset Management LP purchased a new stake in Moderna, Inc. (NASDAQ:MRNA - Free Report) in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 36,954 shares of the company's stock, valued at approximateDecember 8, 2024 | marketbeat.comTwo Sigma Advisers LP Acquires Shares of 356,500 Moderna, Inc. (NASDAQ:MRNA)Two Sigma Advisers LP bought a new position in Moderna, Inc. (NASDAQ:MRNA - Free Report) during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 356,500 shares of the company's stock, valued atDecember 8, 2024 | marketbeat.comState Street Corp Buys 1,823,276 Shares of Moderna, Inc. (NASDAQ:MRNA)State Street Corp increased its stake in Moderna, Inc. (NASDAQ:MRNA - Free Report) by 12.1% in the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 16,847,212 shares of the company's stock after purchasing an additional 1,823,276 shares during the quarterDecember 8, 2024 | marketbeat.comModerna CEO says he'll work with Trump using 'facts and data'December 6, 2024 | yahoo.comModerna opens Southern Hemisphere’s only mRNA manufacturing facility in VictoriaDecember 6, 2024 | msn.comModerna, Inc. (MRNA) Piper Sandler 36th Annual Healthcare Conference (Transcript)December 5, 2024 | seekingalpha.comModerna, Inc. (NASDAQ:MRNA) President Sells $13,596.20 in StockDecember 5, 2024 | insidertrades.comIs Now the Time to Buy 3 of the S&P 500's Worst-Performing Stocks of 2024?December 5, 2024 | fool.comRockefeller Capital Management L.P. Lowers Stake in Moderna, Inc. (NASDAQ:MRNA)Rockefeller Capital Management L.P. reduced its holdings in shares of Moderna, Inc. (NASDAQ:MRNA - Free Report) by 61.4% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 68,205 shares of the company's stocDecember 5, 2024 | marketbeat.com Get Moderna News Delivered to You Automatically Sign up to receive the latest news and ratings for MRNA and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Humiliated: Demo of Elon’s Tech Proves They’re Wrong (Ad)Elon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it. Click here to watch this demo and decide for yourself. MRNA Media Mentions By Week MRNA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MRNA News Sentiment▼0.200.61▲Average Medical News Sentiment MRNA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MRNA Articles This Week▼2123▲MRNA Articles Average Week Get Moderna News Delivered to You Automatically Sign up to receive the latest news and ratings for MRNA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Takeda Pharmaceutical News BioNTech News Teva Pharmaceutical Industries News BeiGene News Viatris News Summit Therapeutics News Genmab A/S News Dr. Reddy's Laboratories News Sarepta Therapeutics News Catalent News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MRNA) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Moderna, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Moderna With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MRNA Stock Alerts